AusPAR: BNT162b2 (mRNA)
Australian Public Assessment Report
Device/Product Name
Comirnaty
Active ingredients
BNT162b2 (mRNA)
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04582-1-2
Submission Type
Major variation (change of dose regimen)
Decision
Approved for provisional registration
This webpage on the TGA website was printed on 21 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/auspar/auspar-bnt162b2-mrna-0